Subtyping of triple-negative breast cancer: Implications for therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Subtyping of triple-negative breast cancer: Implications for therapy

Published:2014-07-16 Issue:1 Volume:121 Page:8-16
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Abramson Vandana G.¹²,Lehmann Brian D.²³,Ballinger Tarah J.¹,Pietenpol Jennifer A.²³

Affiliation:

1. Department of Medicine, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine; Nashville Tennessee

2. Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine; Nashville Tennessee

3. Department of Biochemistry, Vanderbilt-Ingram Cancer Center; Vanderbilt University School of Medicine; Nashville Tennessee

Funder

NIH

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28914/fullpdf

Reference52 articles.

1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007

2. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study;Carey;JAMA,2006

3. Molecular portraits of human breast tumours;Perou;Nature,2000

4. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma;Makretsov;Clin Cancer Res,2004

5. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype;Cheang;Clin Cancer Res,2008

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy;Nuclear Medicine and Biology;2024-09

2. Dual-target EZH2 inhibitor: latest advances in medicinal chemistry;Future Medicinal Chemistry;2024-07-31

3. Defining the Regulatory Logic of Breast Cancer Using Single-Cell Epigenetic and Transcriptome Profiling;2024-06-17

4. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies;eBioMedicine;2024-04

5. Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens;Risk Management and Healthcare Policy;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3